Adaptimmune Therapeutics (ADAP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.58

-0.38%

After-hours Dec 13, 2024, 07:03 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	60.28M	27.15M	6.15M	3.96M	1.12M	59.51M	37.83M	14.20M	10.72M	604.63K	-
Cost of Revenue	9.86M	127.73M	111.09M	91.57M	97.50M	-	-	-	-	-	-
Gross Profit	50.42M	-100.58M	-104.94M	-87.61M	-96.38M	59.51M	37.83M	14.20M	10.72M	604.63K	-
Operating Income	-138.04M	-163.97M	-162.25M	-133.41M	-139.77M	-82.36M	-80.66M	-72.80M	-23.07M	-14.37M	-9.35M
Interest Income	5.96M	1.54M	1.09M	2.31M	2.77M	2.85M	2.23M	1.11M	787.00K	3.41K	13.68K
Pretax Income	-112.53M	-162.96M	-157.30M	-129.93M	-136.92M	-95.02M	-69.69M	-70.69M	-23.69M	-14.37M	-9.34M
Net Income	-113.87M	-165.46M	-158.09M	-130.09M	-137.16M	-95.51M	-70.14M	-71.58M	-21.59M	-12.70M	-8.46M
Selling & General & Admin	71.81M	63.39M	57.30M	45.80M	43.39M	43.60M	31.11M	23.21M	11.32M	2.73M	1.21M
Research & Development	126.51M	127.73M	111.09M	91.57M	97.50M	98.27M	87.39M	63.79M	23.19M	12.53M	8.15M
Other Expenses	-	-536.00K	3.85M	1.16M	75.00K	-15.50M	8.74M	1.00M	-726.50K	-281.02K	-
Operating Expenses	200.02M	191.11M	168.40M	137.36M	140.89M	141.87M	118.49M	87.00M	33.79M	14.98M	9.35M
Interest Expense	-	-	-	-	-	376.00K	2.23M	-	-	6.81K	6.08K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	198.28M	191.11M	168.40M	137.36M	140.89M	141.87M	118.49M	87.00M	33.79M	14.98M	9.35M
Income Tax	1.34M	2.50M	791.00K	162.00K	242.00K	497.00K	451.00K	892.00K	-2.11M	-1.67M	-878.67K
Shares Outstanding (Basic)	201.07M	161.21M	155.81M	142.46M	104.97M	97.39M	87.94M	70.79M	35.78M	424.71M	424.71M
Shares Outstanding (Diluted)	201.07M	161.21M	155.81M	142.46M	104.97M	97.39M	87.94M	70.79M	35.78M	424.71M	424.71M
EPS (Basic)	-0.57	-1.03	-1.01	-0.91	-1.31	-0.98	-0.8	-1.01	-0.6	-0.03	-0.02
EPS (Diluted)	-0.57	-1.03	-1.01	-0.91	-1.31	-0.98	-0.8	-1.01	-0.6	-0.03	-0.02
EBITDA	-128.20M	-155.59M	-155.68M	-125.81M	-131.76M	-74.56M	-75.24M	-69.51M	-23.77M	-23.91M	-11.28M
Depreciation & Amortization	9.84M	6.07M	6.57M	7.65M	8.04M	7.81M	5.42M	3.29M	732.78K	250.37K	45.60K